Evidence map›Paper›PMID 26421053›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2015

Validation of a RP-HPLC-DAD Method for Chamomile (Matricaria recutita) Preparations and Assessment of the Marker, Apigenin-7-glucoside, Safety and Anti-Inflammatory Effect.

Felipe Galeti Miguel, Amanda Henriques Cavalheiro, Nathália Favaretto Spinola, Diego Luis Ribeiro, Gustavo Rafael Mazzaron Barcelos, Lusânia Maria Greggi Antunes, Juliana Issa Hori, Franciane Marquele-Oliveira, Bruno Alves Rocha, Andresa Aparecida Berretta

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Apigenin 7-glucoside reprograms tumor metabolism and enhances immunotherapy efficacy in colorectal cancer via DLX5.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Ethnopharmacological Effects ofAntioxidants (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Development of a quantified herbal extract of hawthornSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Felipe Galeti MiguelLaboratório de Pesquisa, Desenvolvimento e Inovação (P, D & I), Apis Flora Industrial e Comercial LTDA, 14020-670 Ribeirão Preto, SP, Brazil.
Amanda Henriques CavalheiroLaboratório de Pesquisa, Desenvolvimento e Inovação (P, D & I), Apis Flora Industrial e Comercial LTDA, 14020-670 Ribeirão Preto, SP, Brazil.
Nathália Favaretto SpinolaLaboratório de Pesquisa, Desenvolvimento e Inovação (P, D & I), Apis Flora Industrial e Comercial LTDA, 14020-670 Ribeirão Preto, SP, Brazil.
Diego Luis RibeiroDepartamento de Genética, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (FMRP-USP), 14055-370 Ribeirão Preto, SP, Brazil.
Gustavo Rafael Mazzaron BarcelosDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), 14040-903 Ribeirão Preto, SP, Brazil.
Lusânia Maria Greggi AntunesDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), 14040-903 Ribeirão Preto, SP, Brazil.
Juliana Issa HoriDepartment of Pharmacology, School of Medicine of Ribeirao Preto, University of Sao Paulo, 14055-370 Ribeirao Preto, SP, Brazil.
Franciane Marquele-OliveiraLaboratório de Pesquisa, Desenvolvimento e Inovação (P, D & I), Apis Flora Industrial e Comercial LTDA, 14020-670 Ribeirão Preto, SP, Brazil.
Bruno Alves RochaDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), 14040-903 Ribeirão Preto, SP, Brazil.
Andresa Aparecida BerrettaLaboratório de Pesquisa, Desenvolvimento e Inovação (P, D & I), Apis Flora Industrial e Comercial LTDA, 14020-670 Ribeirão Preto, SP, Brazil ; Departamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), 14040-903 Ribeirão Preto, SP, Brazil.
Universidade de São Paulo · BRApis Flora (Brazil) · BRUniversidade de Ribeirão Preto · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chamomile is a medicinal plant, which presents several biological effects, especially the anti-inflammatory effect. One of the compounds related to this effect is apigenin, a flavonoid that is mostly found in its glycosylated form, apigenin-7-glucoside (APG), in natural sources. However, the affectivity and safety of this glycoside have not been well explored for topical application. In this context, the aim of this work was to develop and validate a reversed-phase high-performance liquid chromatography (RP-HPLC-DAD) method to quantify APG in chamomile preparations. Additionally, the safety and the anti-inflammatory potential of this flavonoid were verified. The RP-HPLC-DAD method was developed and validated with linearity at 24.0-36.0 μg/mL range (r = 0.9994). Intra- and interday precision (RSD) were 0.27-2.66% and accuracy was 98.27-101.21%. The validated method was applied in the analysis of chamomile flower heads, glycolic extract, and Kamillen cream, supporting the method application in the quality control of chamomile preparations. Furthermore, the APG safety was assessed by MTT cytotoxicity assay and mutagenic protocols and the anti-inflammatory activity was confirmed by a diminished TNF-α production showed by mice macrophages treated with APG following LPS treatment.

Identifiers

PMID26421053
PMCPMC4573433
OpenAlexW1629446360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.